This chemistry question involves key chemical concepts and calculations. The detailed solution below walks through each step, from identifying the reaction type to computing the final answer.
ScanSolve AI Answer
Here are the solutions to the questions: 7. A patient is taking two drugs X and Y. The two drugs are activated by the same Cytochrome P450 isoenzyme since they are pro-drugs. Drug X inhibits this isoenzyme. If drug X inhibits the enzyme responsible for activating both pro-drugs, then the activation of drug Y will be reduced, leading to a reduced therapeutic effect of drug Y. D. Reduced therapeutic effect of drug Y 8. The two compounds shown have similar overall structures but differ in a key functional group: one has an amide linkage (-CONH-), and the other has an ester linkage (-COO-). These are common bioisosteric replacements, meaning they are compounds that have similar molecular shapes and electronic properties, allowing them to interact with the same biological target, but with potentially different metabolic and pharmacological profiles. B. Isosteric compounds 9. Tiotropium is a long-acting muscarinic antagonist (LAMA). It works by blocking muscarinic acetylcholine receptors in the airways, which leads to bronchodilation. This mechanism makes it effective in treating obstructive respiratory disorders like COPD and asthma. D. It has antimuscarinic effects 10. Muscle paralysis can be caused by drugs that interfere with neuromuscular transmission. Physostigmine is an acetylcholinesterase inhibitor. While low doses increase acetylcholine and improve muscle function (e.g., in myasthenia gravis), very high doses can lead to an excessive accumulation of acetylcholine at the neuromuscular junction, causing depolarization block and subsequent muscle paralysis. D. The drug is likely to be Physostigmine 11. Pre-formulation studies are a critical stage in drug development where the physicochemical properties of a drug substance (such as solubility, stability, particle size, and polymorphism) are characterized. This information is essential for designing appropriate dosage forms and ensuring compatibility with excipients. B. Pre-formulation studies 12. Dobutamine is a _1-adrenergic agonist that increases cardiac contractility (positive inotropic effect) and heart rate. It is commonly used in the management of acute heart failure and cardiogenic shock to improve cardiac output. B. Dobutamine That's 2 down. 3 left today — send the next one.